1. Ark Therapeutics pioneers gene therapy

    Interviewee/Contributer: Nigel Parker

    Organisation: Ark Therapeutics Plc

    Read more

  2. Preparing for the advanced therapy Regulation

    Interviewee/Contributer: 

    Organisation: 

    Read more

  3. Discovering biomarkers for Alzheimer's disease

    Interviewee/Contributer: Simon Lovestone

    Organisation: Institute of Psychiatry, King's College Hospital

    Read more

  4. Nextech Venture exalts the specialist

    Interviewee/Contributer: Alfred Scheidegger

    Organisation: Nextech Venture AG

    Read more

  5. How Innate Pharma turned a threat into an opportunity

    Interviewee/Contributer: Herve Brailly

    Organisation: Innate Pharma SA

    Read more

  6. Wellcome Trust rises to the antibiotic challenge

    Interviewee/Contributer: Ted Bianco

    Organisation: Wellcome Trust

    Read more

  7. Cell Medica takes a new approach to personalised medicine

    Interviewee/Contributer: Gregg Sando

    Organisation: Cell Medica

    Read more

  8. The Seroxat investigation and subsequent legal initiatives

    Interviewee/Contributer: 

    Organisation: 

    Read more

  9. Oxford Capital Partners assesses the funding outlook

    Interviewee/Contributer: David Mott

    Organisation: Oxford Capital Partners Ltd

    Read more

  10. How Ablynx uses the llama to create antibodies

    Interviewee/Contributer: Edwin Moses

    Organisation: Ablynx NV

    Read more